Achieving Goal Blood Pressure in Patients With Type 2 Diabetes: Conventional Versus Fixed‐Dose Combination Approaches
Authors:
- George L. BakrisGBGeorge L. Bakris
- Matthew R. WeirMWMatthew R. Weir
- on behalf of the Study of Hypertension and the Efficacy of Lotrel in Diabetes (SHIELD) InvestigatorsOIon behalf of the Study of Hypertension and the Efficacy of Lotrel in Diabetes (SHIELD) Investigators
- 21 May 2003
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 5 (3) , 202-209
Abstract
Data from the Third National Health and Nutrition Examination Survey (NHANES III) demonstrate that only 11% of people with diabetes who are treated for high blood pressure achieve the blood pressure goal of p=0.001). At 3 months, more participants in the combination group achieved treatment goal (63% combination vs. 37% conventional; p=0.002). Data analysis at 3 months comparing blood pressure control rates between the fixed‐dose combination group (with out HCTZ) to the conventional group (receiving HCTZ) showed an even greater disparity in blood pressure goal achievement (87% combination without HCTZ vs. 37% conventional group with HCTZ; p=0.0001). We conclude that initial therapy with a fixed‐dose combination may be more efficacious than conventional monotherapy approaches for achieving blood pressure goals in the diabetic patient. A fixed‐dose combination approach appears as safe as the current conventional approaches.Keywords
This publication has 42 references indexed in Scilit:
- The Prevention or Delay of Type 2 DiabetesDiabetes Care, 2002
- IntroductionDiabetes Care, 2002
- Diabetes, Hypertension, and Cardiovascular DiseaseHypertension, 2001
- Pharmacoeconomics of Hypertension ManagementPharmacoEconomics, 2001
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Diuretics and β-blockers: Is there a risk for dyslipidemia?American Heart Journal, 2000
- Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic HypertensionNew England Journal of Medicine, 1999
- Influence of Race and Dietary Salt on the Antihypertensive Efficacy of an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Antagonist in Salt-Sensitive HypertensivesHypertension, 1998
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of internal medicine (1960), 1997
- Diabetes mellitus and raised serum triglyceride concentration in treated hypertension—are they of prognostic importance? Observational studyBMJ, 1996